LINDSAY TOMKIEWICZ: Open Payments
NPI 1265195739 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,556 in 83 payments from 16 companies in 2025. Trend: 2023 $356 · 2024 $1,673 · 2025 $1,556
Food & beverage: $1,556
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $380 |
| GENZYME CORPORATION | 8 | $224 |
| Janssen Biotech, Inc. | 24 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $175 |
| Lilly USA, LLC | 2 | $137 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| Boston Scientific Corporation | 1 | $84 |
| Gilead Sciences, Inc. | 2 | $48 |
| Ardelyx, Inc. | 3 | $46 |
| Intercept Pharmaceuticals, Inc. | 2 | $34 |
Products named: DUPIXENT, TREMFYA, RINVOQ, ENTYVIO, ZEPBOUND, Axios, CREON, LINZESS.
Industry payments across IN — which companies pay providers there.
